Gordon Broderick: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author")
m (Undo revision 110652 by Notjusttired (talk))
Line 29: Line 29:
*2012, Cytokine expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480896/ (Full Text)]
*2012, Cytokine expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480896/ (Full Text)]
*2014, A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: [[Gulf War Illness]] and Chronic Fatigue Syndrome<ref>{{Citation
*2014, A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: [[Gulf War Illness]] and Chronic Fatigue Syndrome<ref>{{Citation
| last1  = Craddock    | first1 = Travis J. A. | authorlink1 = Travis Craddock |last2  = Fritsch |first    2  |authorlink2 = |last3  = Rice, Jr |first    3  |authorlink3 =  
| last1  = Craddock    | first1 = Travis J. A. | authorlink1 = Travis Craddock
| last4  = del Rosario | first4 = Ryan M.      | authorlink4 = |last5  = Miller |first      5  |authorlink5 = |last6  = Fletcher |first    6  |authorlink6 = Mary Ann Fletcher |last7  = Klimas |first      7  |authorlink7 = Nancy Klimas  
| last2  = Fritsch     | first2 = Paul        | authorlink2 =  
| last3  = Rice, Jr   | first3 = Mark A.      | authorlink3 =  
| last4  = del Rosario | first4 = Ryan M.      | authorlink4 =  
| last5  = Miller     | first5 = Diane B.    | authorlink5 =  
| last6  = Fletcher   | first6 = Mary Ann    | authorlink6 = Mary Ann Fletcher
| last7  = Klimas     | first7 = Nancy G.    | authorlink7 = Nancy Klimas  
| last8  = Broderick  | first8 = Gordon      | authorlink8 = Gordon Broderick
| last8  = Broderick  | first8 = Gordon      | authorlink8 = Gordon Broderick
| title  = A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome
| title  = A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome
Line 75: Line 80:
<ref name="Aspler, 2008">{{Citation
<ref name="Aspler, 2008">{{Citation
| last1  = Aspler    | first1 = AL             
| last1  = Aspler    | first1 = AL             
| last2  = Bolshin    | first2 = C           |last3  = Vernon |first    3  |authorlink3 = Suzanne Vernon
| last2  = Bolshin    | first2 = C        
| last3  = Vernon     | first3 = SD        | authorlink3 = Suzanne Vernon
| last4  = Broderick  | first4 =G          | authorlink4 = Gordon Broderick
| last4  = Broderick  | first4 =G          | authorlink4 = Gordon Broderick
| title  = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood  
| title  = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood  
Line 84: Line 90:
</ref>
</ref>
<ref name="Broderick, 2010">{{Citation
<ref name="Broderick, 2010">{{Citation
| last1  = Broderick  | first1 = Gordon        | authorlink1 = Gordon Broderick |last2  = Fuite |first      2  |authorlink2 = |last3  = Kreitz |first      3  |authorlink3 = |last4  = Vernon |first      4  |authorlink4 = Suzanne Vernon |last5  = Klimas |first      5  |authorlink5 = Nancy Klimas |last6  = Fletcher |first    6  |authorlink6 = Mary Ann Fletcher   
| last1  = Broderick  | first1 = Gordon        | authorlink1 = Gordon Broderick
| last2  = Fuite       | first2 = Jim            | authorlink2 =  
| last3  = Kreitz     | first3 = Andrea        | authorlink3 =  
| last4  = Vernon     | first4 = Suzanne        | authorlink4 = Suzanne Vernon  
| last5  = Klimas     | first5 = Nancy          | authorlink5 = Nancy Klimas  
| last6  = Fletcher   | first6 = Mary Ann      | authorlink6 = Mary Ann Fletcher   
| title  = A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome
| title  = A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome
| journal = Brain, Behavior, and Immunity  | volume = 24  | issue = 7  | page = 1209–1217
| journal = Brain, Behavior, and Immunity  | volume = 24  | issue = 7  | page = 1209–1217
Line 91: Line 102:
}}
}}
</ref>
</ref>
<ref name="Broderick, 2012">{{Citation |last1  = Broderick |first      1  |authorlink1 = Gordon Broderick |last2  = Katz |first          2  |authorlink2 = Ben Katz |last3  = Fernandes |first      3  |authorlink3 = |last4  = Fletcher |first       4  |authorlink4 = Mary Ann Fletcher   |last5  = Klimas |first        5  |authorlink5 = Nancy Klimas |last6  = Smith |first          6  |authorlink6 = |last7  = O'Gorman |first      7  |authorlink7 = |last8  = Vernon |first        8  |authorlink8 = Suzanne Vernon |last9  = Taylor |first        9  |authorlink9 = Renee Taylor  
<ref name="Broderick, 2012">{{Citation
| last1  = Broderick     | first1 = Gordon        | authorlink1 = Gordon Broderick
| last2  = Katz           | first2 = Ben Z          | authorlink2 = Ben Katz
| last3  = Fernandes     | first3 = Henrique      | authorlink3 =  
| last4  = Fletcher       | first4 = Mary Ann       | authorlink4 = Mary Ann Fletcher
| last5  = Klimas         | first5 = Nancy          | authorlink5 = Nancy Klimas  
| last6  = Smith         | first6 = Frederick A    | authorlink6 =  
| last7  = O'Gorman       | first7 = Maurice RG    | authorlink7 =
| last8  = Vernon         | first8 = Suzanne D      | authorlink8 = Suzanne Vernon
| last9  = Taylor         | first9 = Renee          | authorlink9 = Renee Taylor  
| title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
| title  = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
| journal = Journal of Translational Medicine  | volume = 10 | issue = 191  | page =  
| journal = Journal of Translational Medicine  | volume = 10 | issue = 191  | page =  
Line 98: Line 118:
}}
}}
</ref>
</ref>
<ref name="Cook, 2017">{{Citation |last1  = Cook |first            1  |authorlink1 = Dane Cook |last2  = Light |first          2  |authorlink2 = Alan Light |last3  = Light |first          3  |authorlink3 = Kathleen Light |last4  = Broderick |first      4  |authorlink4 = Gordon Broderick |last5  = Shields |first        5  |authorlink5 = |last6  = Dougherty |first      6  |authorlink6 = |last7  = Meyer |first          7  |authorlink7 = |last8  = VanRiper |first        8  |authorlink8 = |last9  = Stegner |first        9  |authorlink9 = |last10  = Ellingson |first      10  |authorlink10 = |last11  = Vernon |first         11  |authorlink11 = Suzanne Vernon  
<ref name="Cook, 2017">{{Citation
| last1  = Cook           | first1 = Dane B.              | authorlink1 = Dane Cook
| last2  = Light           | first2 = Alan R.              | authorlink2 = Alan Light
| last3  = Light           | first3 = Kathleen C.          | authorlink3 = Kathleen Light
| last4  = Broderick       | first4 = Gordon              | authorlink4 = Gordon Broderick
| last5  = Shields         | first5 = Morgan R.            | authorlink5 =  
| last6  = Dougherty       | first6 = Ryan J.              | authorlink6 =  
| last7  = Meyer           | first7 = Jacob D.            | authorlink7 =  
| last8  = VanRiper       | first8 = Stephanie            | authorlink8 =  
| last9  = Stegner         | first9 = Aaron J.            | authorlink9 =  
| last10  = Ellingson       | first10 = Laura D.            | authorlink10 =
| last11  = Vernon         | first11 = Suzanne D.         | authorlink11 = Suzanne Vernon  
| title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
| title  = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
| journal = Brain, Behavior, and Immunity    | volume =    | issue =    | page =  
| journal = Brain, Behavior, and Immunity    | volume =    | issue =    | page =  
Line 106: Line 137:
}}
}}
</ref>
</ref>
<ref name="Fuite, 2010">{{Citation |last1  = Fuite |first             1  |authorlink1 =   |last2  = Vernon |first            2  |authorlink2 = Suzanne Vernon |last3  = Broderick |first          3  |authorlink3 = Gordon Broderick   
<ref name="Fuite, 2010">{{Citation
| last1  = Fuite             | first1 = Jim             | authorlink1 =
| last2  = Vernon             | first2 = Suzanne          | authorlink2 = Suzanne Vernon  
| last3  = Broderick         | first3 = Gordon          | authorlink3 = Gordon Broderick   
| title  = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
| title  = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.
| journal = Genomics  | volume = 92  | issue = 6  | page = 393-9
| journal = Genomics  | volume = 92  | issue = 6  | page = 393-9
Line 113: Line 147:
}}
}}
</ref>
</ref>
<ref name="Klimas, 2012">{{Citation |last1  = Klimas |first             1  |authorlink1 = Nancy Klimas |last2  = Broderick |first          2  |authorlink2 = Gordon Broderick |last3  = Fletcher |first            3  |authorlink3 = Mary Ann Fletcher
<ref name="Klimas, 2012">{{Citation
| last1  = Klimas             | first1 = NG             | authorlink1 = Nancy Klimas
| last2  = Broderick           | first2 = G              | authorlink2 = Gordon Broderick
| last3  = Fletcher           | first3 = MA              | authorlink3 = Mary Ann Fletcher
| title  = Biomarkers for chronic fatigue.
| title  = Biomarkers for chronic fatigue.
| journal = Brain Behav Immun    | volume = 26  | issue =  8  | page = 1202-10
| journal = Brain Behav Immun    | volume = 26  | issue =  8  | page = 1202-10
Line 121: Line 158:
}}
}}
</ref>
</ref>
<ref name="Nakamura, 2010">{{Citation |last1  = Nakamura |first        1  |authorlink1 = |last2  = Schwander |first        2  |authorlink2 = |last3  = Donnelly |first        3  |authorlink3 = |last4  = Ortega |first          4  |authorlink4 = |last5  = Togo |first             5  |authorlink5 = |last6  = Broderick |first        6  |authorlink6 = Gordon Broderick |last7  = Yamamoto |first        7  |authorlink7 = |last8  = Cherniack |first        8  |authorlink8 = |last9  = Rapoport |first        9  |authorlink9 = |last10  = Natelson |first        10  |authorlink10 = Benjamin Natelson  
<ref name="Nakamura, 2010">{{Citation
| last1  = Nakamura         | first1 = T            | authorlink1 =  
| last2  = Schwander       | first2 = S            | authorlink2 =  
| last3  = Donnelly         | first3 = R            | authorlink3 =  
| last4  = Ortega           | first4 = F            | authorlink4 =  
| last5  = Togo             | first5 = F             | authorlink5 =  
| last6  = Broderick       | first6 = G            | authorlink6 = Gordon Broderick
| last7  = Yamamoto         | first7 = Y            | authorlink7 =  
| last8  = Cherniack       | first8 = NS            | authorlink8 =  
| last9  = Rapoport         | first9 = D            | authorlink9 =
| last10  = Natelson         | first10 = BH          | authorlink10 = Benjamin Natelson  
| title  = Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia
| title  = Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia
| journal = Clinical and Vaccine Immunology  | volume = 17  | issue = 4  | page = 582–587
| journal = Clinical and Vaccine Immunology  | volume = 17  | issue = 4  | page = 582–587
Line 129: Line 176:
}}
}}
</ref>
</ref>
<ref name="Russell, 2016">{{Citation |last1  = Russell |first           1  |authorlink1 = |last2  = Broderick |first        2  |authorlink2 = Gordon Broderick |last3  = Taylor |first            3  |authorlink3 = Renee Taylor |last4  = Fernandes |first        4  |authorlink4 = |last5  = Harvey |first           5  |authorlink5 = |last6  = Barnes |first            6  |authorlink6 = Zachary Barnes |last7  = Smylie |first            7  |authorlink7 = |last8  = Collado |first          8  |authorlink8 = |last9  = Balbin |first            9  |authorlink9 = |last10  = Katz |first              10  |authorlink10 = Ben Katz |last11  = Klimas |first           11  |authorlink11 = Nancy Klimas |last12  = Fletcher |first          12  |authorlink12 = Mary Ann Fletcher
<ref name="Russell, 2016">{{Citation
| last1  = Russell           | first1 = Lindsey           | authorlink1 =  
| last2  = Broderick         | first2 = Gordon            | authorlink2 = Gordon Broderick
| last3  = Taylor           | first3 = Renee            | authorlink3 = Renee Taylor
| last4  = Fernandes         | first4 = Henrique          | authorlink4 =  
| last5  = Harvey           | first5 = Jeanna           | authorlink5 =  
| last6  = Barnes           | first6 = Zachary          | authorlink6 = Zachary Barnes
| last7  = Smylie           | first7 = AnneLiese        | authorlink7 =  
| last8  = Collado           | first8 = Fanny            | authorlink8 =  
| last9  = Balbin           | first9 = Elizabeth G.      | authorlink9 =  
| last10  = Katz             | first10 = Ben Z.          | authorlink10 = Ben Katz  
| last11  = Klimas           | first11 = Nancy           | authorlink11 = Nancy Klimas
| last12  = Fletcher         | first12 = Mary Ann        | authorlink12 = Mary Ann Fletcher
| title  = Illness progression in chronic fatigue syndrome: a shifting immune baseline  
| title  = Illness progression in chronic fatigue syndrome: a shifting immune baseline  
| journal = BMC Immunology    | volume = 17  | issue = 3  | page =  
| journal = BMC Immunology    | volume = 17  | issue = 3  | page =  

Revision as of 21:39, May 11, 2022

Source: nova.edu

Gordon Broderick, PhD, is an associate professor at the University of Alberta, as well as part of Dr. Nancy Klimas’ Institute for Neuro Immune Medicine at Nova Southeastern University (NSU). He regularly serves on National Institutes of Health (NIH) study sections for chronic fatigue syndrome research.[1]

Education[edit | edit source]

  • Undergarduate - Mechanical Engineering from McGill University
  • Masters - Chemical Engineering from McGill University
  • Doctorate - Chemical Engineering from the University of Montreal
  • Post-doctorate - McGill’s School of Computer Science in cancer genomics
  • Research fellowship - Computational Biochemistry at the University of Alberta[2]

International Consensus Criteria[edit | edit source]

Dr Broderick participated in the team that authored the 2011 case definition, International Consensus Criteria (ICC).[3]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Broderick, along with 41 colleagues in the ME/CFS field, signed the second letter.

Notable studies in ME/CFS[edit | edit source]


Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ Gordon Broderick, Ph.D. - University of Alberta
  2. ↑ "NOVA bio".
  3. ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
  4. ↑ Tuller, Date (February 10, 2016). "An open letter to The Lancet, again". Virology blog. Retrieved August 14, 2018.
  5. ↑ Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008), "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood", Behavioral and Brain Functions, 4 (44), doi:10.1186/1744-9081-4-44
  6. ↑ Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008), "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.", Genomics, 92 (6): 393-9, doi:10.1016/j.ygeno.2008.08.008
  7. ↑ Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Hurwitz, Barry; Antoni, Michael; Broderick, Gordon; Klimas, Nancy G. (May 25, 2010). Unutmaz, Derya (ed.). "Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26". PLoS ONE. 5 (5): e10817. doi:10.1371/journal.pone.0010817. ISSN 1932-6203. PMC 2876037. PMID 20520837.
  8. ↑ Broderick, Gordon; Fuite, Jim; Kreitz, Andrea; Vernon, Suzanne; Klimas, Nancy; Fletcher, Mary Ann (2010), "A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome", Brain, Behavior, and Immunity, 24 (7): 1209–1217, doi:10.1016/j.bbi.2010.04.012
  9. ↑ Nakamura, T; Schwander, S; Donnelly, R; Ortega, F; Togo, F; Broderick, G; Yamamoto, Y; Cherniack, NS; Rapoport, D; Natelson, BH (2010), "Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia", Clinical and Vaccine Immunology, 17 (4): 582–587, doi:10.1128/CVI.00379-09
  10. ↑ Fletcher, Mary Ann; Rosenthal, Martin; Antoni, Michael; Ironson, Gail; Zeng, Xiao R; Barnes, Zachary; Harvey, Jeanna M; Hurwitz, Barry; Levis, Silvina; Broderick, Gordon; Klimas, Nancy G (2010), "Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome", Behavioral and Brain Functions, 6 (76), doi:10.1186/1744-9081-6-76
  11. ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
  12. ↑ Klimas, NG; Broderick, G; Fletcher, MA (2012), "Biomarkers for chronic fatigue.", Brain Behav Immun, 26 (8): 1202-10, doi:10.1016/j.bbi.2012.06.006, PMID 22732129
  13. ↑ Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012), "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue", Journal of Translational Medicine, 10 (191), doi:10.1186/1479-5876-10-191
  14. ↑ Craddock, Travis J. A.; Fritsch, Paul; Rice, Jr, Mark A.; del Rosario, Ryan M.; Miller, Diane B.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon (2014), "A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome", PLOS One, 9 (1): e84839, doi:10.1371/journal.pone.0084839
  15. ↑ Craddock, Travis J.A.; Harvey, Jeanna M.; Nathanson, Lubov; Barnes, Zachary M.; Klimas, Nancy G.; Fletcher, Mary Ann; Broderick, Gordon (July 9, 2015). "Using gene expression signatures to identify novel treatment strategies in gulf war illness". BMC Medical Genomics. 8. doi:10.1186/s12920-015-0111-3. ISSN 1755-8794. PMC 4495687. PMID 26156520.
  16. ↑ Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R. G.; Vernon, Suzanne D.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
  17. ↑ Russell, Lindsey; Broderick, Gordon; Taylor, Renee; Fernandes, Henrique; Harvey, Jeanna; Barnes, Zachary; Smylie, AnneLiese; Collado, Fanny; Balbin, Elizabeth G.; Katz, Ben Z.; Klimas, Nancy; Fletcher, Mary Ann (2016), "Illness progression in chronic fatigue syndrome: a shifting immune baseline", BMC Immunology, 17 (3), doi:10.1186/s12865-016-0142-3
  18. ↑ Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, Jacob D.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, Laura D.; Vernon, Suzanne D. (2017), "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2017.02.009
  19. ↑ Sedghamiz, Hooman; Morris, Matthew; Craddock, Travis J. A.; Whitley, Darrell; Broderick, Gordon (July 17, 2018). "High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology". BMC Systems Biology. 12 (76). doi:10.1186/s12918-018-0599-1.
  20. ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.
  21. ↑ Klimas, N.G.; Fletcher, M.A.; Abreu, M.M.; Aenlle, K.; Craddock, T.; Broderick, G. (February 2019). "From biomarkers to targeted treatment: The myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and gulf war illness (GWI) story". Brain, Behavior, and Immunity. 76: e40. doi:10.1016/j.bbi.2018.11.301.
  22. ↑ Richman, Spencer; Morris, Matthew C.; Broderick, Gordon; Craddock, Travis J.A.; Klimas, Nancy G.; Fletcher, Mary Ann (March 2019). "Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.02.011.
  23. ↑ Jeffrey, Mary G.; Nathanson, Lubov; Aenlle, Kristina; Barnes, Zachary M.; Baig, Mirza; Broderick, Gordon; Klimas, Nancy G.; Fletcher, Mary Ann; Craddock, Travis J.A. (March 2019). "Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.01.011.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

International Consensus Criteria (ICC) - A set of diagnostic criteria, based on the Canadian Consensus Criteria, that argued for the abandonment of the term "chronic fatigue syndrome" and encouraged the sole use of the term "myalgic encephalomyelitis".

cytokine any class of immunoregulatory proteins secreted by cells, especially immune cells. Cytokines are small proteins important in cell signaling that modulate the immune system. (Learn more: me-pedia.org)

plasma The liquid part of blood, lymph, or milk after removing any suspended material. Most of the time, "plasma" simply refers to blood, after all the blood cells have been removed. If you also remove the clotting factors, then the plasma is referred to as "serum".

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic illness any long-term illness, regardless of the severity. Chronic illnesses are typically incurable, requiring long-term management.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

cytokine any class of immunoregulatory proteins secreted by cells, especially immune cells. Cytokines are small proteins important in cell signaling that modulate the immune system. (Learn more: me-pedia.org)

Retrieved from "https://me-pedia.org/w/index.php?title=Gordon_Broderick&oldid=111221"